Reviewing LORELEI, mindACT and ExteNET trials in breast cancer

Prof Martin talks with ecancer at the ESMO 2017 Congress and reviews a breast cancer session that examined three trials: - The ExteNET trail, looking at the use of neratinib for the extended adjuvant treatment of early stage HER2-positive breast...

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2eV8eec
via IFTTT